Cryoablation for renal tumors: Current status

Andre Berger, Kazumi Kamoi, Inderbir S. Gill, Monish Aron

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


Purpose of review To review the evolution and current status of cryoablation for renal tumors. Recent findings Cryoablation is the most evaluated probe ablative method for the treatment of small renal masses. It is associated with high efficacy and low morbidity. New data on intermediate and long-term oncological outcomes are now available. Five and 10-year cancer-specific survival are 93 and 81%, respectively. Renal cryoablation is most commonly performed percutaneously or laparoscopically. Recently, single-port laparoscopic and natural orifice transluminal endoscopic surgery approaches have also been employed for renal cryotherapy. Summary With careful patient selection, the intermediate-term and long-term oncologic outcomes after cryoablation for kidney tumors are satisfactory. Combination with new technologies and further development of imaging techniques can potentially expand the range of indications of the procedure.

Original languageEnglish (US)
Pages (from-to)138-142
Number of pages5
JournalCurrent opinion in urology
Issue number2
StatePublished - Mar 2009
Externally publishedYes


  • Cryoablation
  • Cryotherapy
  • Kidney tumor
  • Nephron sparing surgery
  • Renal cell carcinoma
  • Renal mass

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Cryoablation for renal tumors: Current status'. Together they form a unique fingerprint.

Cite this